( ( ( Leucocyte subpopulations ) ( from ( ( normally healthy ) individuals ) ) ) ( ( were ( ( ( identified ( by ( ( recognized combinations ) ( of ( ( fluorochrome-conjugated antibodies ) ( to ( CD markers ) ) ) ) ) ) ) and ) ( stained ( by ( ( ( ( ( ( ( different monoclonal ) antibodies ) ( -LRB- ( MAb -RRB- ) ) ) to ) ( ( normal ( cellular ( prion protein ) ) ) ( -LRB- ( PrPC -RRB- ) ) ) ) , ) ( including ( the ( 3F4 MAb ) ) ) ) ) ) ) ) . ) )
(ROOT (S (NP (NP (JJ Leucocyte) (NNS subpopulations)) (PP (IN from) (NP (ADJP (ADVP (RB normally)) (JJ healthy)) (NNS individuals)))) (VP (VBD were) (VP (VP (VBN identified) (PP (IN by) (NP (NP (VBN recognized) (NNS combinations)) (PP (IN of) (NP (NP (JJ fluorochrome-conjugated) (NNS antibodies)) (PP (TO to) (NP (NN CD) (NNS markers)))))))) (CC and) (VP (VBN stained) (PP (IN by) (NP (NP (NP (ADJP (JJ different) (JJ monoclonal)) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NNP MAb)) (-RRB- -RRB-)) (TO to) (NP (NP (JJ normal) (JJ cellular) (NN prion) (NN protein)) (PRN (-LRB- -LRB-) (NP (NNP PrPC)) (-RRB- -RRB-)))) (, ,) (PP (VBG including) (NP (DT the) (CD 3F4) (NN MAb)))))))) (. .)))
Leucocyte subpopulations from normally healthy individuals were identified by recognized combinations of fluorochrome-conjugated antibodies to CD markers and stained by different monoclonal antibodies (MAb) to normal cellular prion protein (PrPC), including the 3F4 MAb.
(ROOT (S (NP (NNS Antibodies)) (VP (VBP recognize) (CC and) (VBP combine) (PP (IN with) (NP (JJ harmful) (NNS materials))) (, ,) (PP (VBG including) (NP (NP (DT both) (JJ toxic) (NNS chemicals)) (CC and) (NP (JJ invasive) (NNS microorganisms))))) (. .)))